[1]
Ariyawongsakul, S., jantrasoontragul, winyoo, Tiratuntayaporn, R. and Nijwattana , C. 2025. A Proof-of-Concept Study for an Intradermal Dose-Sparing Strategy: Non-Inferior Immunogenicity and Improved Systemic Tolerability of Fractional-Dose ChAdOx1-S SARS-CoV-2 Vaccine Compared to Intramuscular Administration. Royal Thai Air Force Medical Gazette. 71, 2 (Dec. 2025), 106–117.